Cargando…
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
BACKGROUND: Despite the efficacy of immunotherapy, only a small percentage of patients achieves a long-term benefit in terms of overall survival. The aim of this study was to define an immune profile predicting the response to immune checkpoint inhibitors (ICIs). METHODS: Patients with advanced soli...
Autores principales: | Botticelli, Andrea, Pomati, Giulia, Cirillo, Alessio, Scagnoli, Simone, Pisegna, Simona, Chiavassa, Antonella, Rossi, Ernesto, Schinzari, Giovanni, Tortora, Giampaolo, Di Pietro, Francesca Romana, Cerbelli, Bruna, Di Filippo, Alessandra, Amirhassankhani, Sasan, Scala, Alessandro, Zizzari, Ilaria Grazia, Cortesi, Enrico, Tomao, Silverio, Nuti, Marianna, Mezi, Silvia, Marchetti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671166/ https://www.ncbi.nlm.nih.gov/pubmed/36405727 http://dx.doi.org/10.3389/fimmu.2022.974087 |
Ejemplares similares
-
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach
por: Botticelli, Andrea, et al.
Publicado: (2023) -
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
por: Mezi, Silvia, et al.
Publicado: (2021) -
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
por: Mezi, Silvia, et al.
Publicado: (2023) -
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
por: Botticelli, Andrea, et al.
Publicado: (2021) -
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
por: Botticelli, Andrea, et al.
Publicado: (2020)